,
Firm Size
- Assets Under Management (AUM):$ N/A
- Number of Funds:
- Employees:
- Firm Type:
Description
New Enterprise Associates (NEA) is a venture capital firm located in Chevy Chase, Maryland. It was founded in 1977 and focuses on investing in early-stage and growth-stage companies in various sectors including technology, healthcare, and energy. NEA aims to provide both financial capital and strategic support to its portfolio companies, helping them scale and succeed. With over $24 billion in committed capital, NEA has made investments in more than 2,000 companies, with notable successes such as Groupon, Workday, and Salesforce. The firm operates globally, with offices in the United States, China, and India, and is known for its extensive network and expertise in identifying and nurturing promising startups. NEA continues to play a significant role in the venture capital industry and remains committed to supporting innovation and entrepreneurship.
Latest News
Powered by
Jun 04, 2024: Twelve Labs Earns $50 Million Series A Co-led by NEA and NVIDIA's NVentures to Build the Future of Multimodal AIMar 12, 2024: Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of EquityRegulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that it has entered into a definitive securities purchase agreement in connection with a private placement to certain institutional investors and other accredited investors. The oversubscribed financing includes participation from new and existing institutional investors, including Adage Capital Partners L.P., Deep Track Capital, the Federated Hermes Kaufmann Funds, New Enterprise Associates (NEA), Octagon Capital, RA Capital Management, and Vivo Capital. Upon the closing of the financing, which is anticipated to occur on or about March 14, 2024, the Company expects to receive gross proceeds of approximately $100 million . The closing of the financing is subject to customary closing conditions.
Feb 08, 2024: Everside Health and Marathon Health Announce Merger to Meet Accelerating Employer Demand for Advanced Primary Care ServicesEverside Health and Marathon Health , leading providers of advanced primary care and occupational health for employer and union-sponsored clients, today announced the closing of their merger to deliver advanced primary care, mental health, occupational health, musculoskeletal and pharmacy services to a combined 2.5 million eligible patients through more than 680 health centers across 41 U.S. states, and virtually in all 50 states.
Nov 09, 2023: Aigen's $12M Series A Unleashes True-Solar Agriculture RobotsAigen, an AI-driven robotics company, closed $12 million in Series A financing from leading investor ReGen Ventures along with NEA, Cleveland Avenue, Incite, and Susquehanna Private Equity Investments LLLP. The funding expands Aigen's manufacturing capacity to meet high pre-order demand and create a new agricultural era that is both sustainable and scalable.
Oct 19, 2023: Transfix Closes $40M Series F Funding Round Led by New Enterprise Associates and G SquaredTransfix, Inc. ("Transfix"), the Intelligent Freight Platform™, today announced the closing of its Series F funding round, led by New Enterprise Associates (NEA) and G Squared, with participation from Canvas.
Oct 10, 2023: Pair Eyewear Announces $75M Series C Funding Round As It Touts Revenue Growth And Enhanced Automated U.S. ManufacturingPair Eyewear , the first direct-to-consumer customizable eyewear brand that is completely reimagining the eyewear industry, announced today that it has raised approximately $75 million in Series C funding. The latest funding round was led by Prysm Capital, with returning investors New Enterprise Associates (NEA), Javelin Venture Partners and continued support from famed NFL player Christian McCaffrey , who also contributed to the Series B raise. To-date, the company has raised $145 million in funding.
Sep 06, 2023: OncoResponse Announces Appointment of Carol Gallagher to Board of DirectorsOncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer Responders, today announced the appointment of Carol Gallagher , Pharm.D., as an Independent Director to its Board of Directors. Dr. Gallagher is an experienced board director and operator who brings over 30 years' experience in drug development, business development, and commercial activities. She currently serves on several private and public boards and is a venture advisor at New Enterprise Associates (NEA), a venture capital firm.
Aug 03, 2023: Insurtech Startup Functional Finance Raises $8 Million to Further Expand Operational Efficiency for the Insurance Industry Functional Finance , a software platform that integrates and automates data and reporting functions for insurance companies, announced today that it has secured $8 million in seed capital, plus $2 million in SAFE notes for future equity investments, which will go towards product development and client relationships. The fundraising round was led by venture capital and growth equity firms New Enterprise Associates, Inc. (NEA) , Walkabout Ventures and Altai Ventures , with participation from industry titan Hank Greenberg's C.V. Starr Insurance and other premier investors.
Jul 11, 2023: NEA Welcomes Mark Hawkins as Venture Partner New Enterprise Associates , Inc. (NEA) today announced that veteran finance organization leader Mark Hawkins has joined the firm as a Venture Partner in its Menlo Park office. Hawkins, who most recently served as President and CFO Emeritus of Salesforce, brings more than 35 years of experience in building and leading finance organizations at some of the world's largest software and technology companies. In this new role, he will work closely with NEA's leadership team and businesses across the firm's technology portfolio as they grow and scale their operations.
Jul 10, 2023: SpyGlass Pharma Completes $90 Million Series C Financing to Advance Novel Treatments for Glaucoma and other Chronic Ophthalmic DiseasesJun 23, 2023: AvoMD Raises $5M to Combat Clinician Burnout With No-Code Clinical App Building PlatformAvoMD, a no-code platform enabling clinicians and hospitals to easily make their own apps for use at the point-of-care, announced it has closed $5 million in seed funding led by early-stage venture fund AlleyCorp. AlleyCorp is joined by Las Olas, Epsilon Health, MedMountain Ventures, notable physician angel investors such as Dr. Kavita Patel , Venture Partner at New Enterprise Associates and Senior Policy Advisor at Stanford University , and existing investors Mirae and Dunamu. Other investors in the company include Columbia University , Mount Sinai Innovation Partners, StartUp Health, and 500 Startups.
Jun 22, 2023: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release TherapeuticsJun 12, 2023: DJUST Raises €12M to Simplify B2B Commerce Across Europe, UK and USDJUST , a B2B eCommerce SaaS platform created by ex-founding member of Mirakl, Arnaud Rihiant, today announced that it has raised €12M in a Series A growth funding round to accelerate market expansion. The funding round was led by New Enterprise Associates, Inc. (NEA) , with additional participation from Elaia Partners .
May 16, 2023: NEA Appoints Technology Investors Aaron Jacobson and Vanessa Larco to Senior Investing Team Roles; Lily Huang, Danielle Lay and Luke Pappas Promoted to PartnerNew Enterprise Associates , Inc. (NEA) today announced several key investing team promotions. Aaron Jacobson and Vanessa Larco , both technology investors, have been elevated to senior investing team roles with appointments to the firm's Venture Capital Investment Committee. NEA also promoted three individuals to Partner: Danielle Lay and Luke Pappas on the technology investing team, and healthcare investor Lily Huang .
May 10, 2023: Orby AI Emerges from Stealth, Announces Funding to Build Generative AI Software That Learns What You Do and Does It For You Today Orby AI ("Orby") has announced that it emerged from stealth to further develop its AI platform designed to democratize the use of Generative AI to automate repetitive human processes. The company also announced that it has raised $4.5M in seed funding from lead investors Pear VC and New Enterprise Associates, Inc. (NEA) , with additional investment from Wing VC . The funding will be used to continue growing the team and further the research and development. Through its beta-stage development thus far, Orby has partnered with some of the world's largest tech enterprises and other medium-sized companies.